I am very pleased to announce the launch of the JGOG International. I strongly hope that this newsletter will gain wide attention and contribute to making clinical research on gynecologic oncology in Japan universally known.
The non-profit organization, the Japanese Gynecologic Oncology Group (JGOG), was established 10 years ago. When the General Assembly and the new Board of Directors of JGOG met on December 5, 2008, I was elected by the Board of Directors as the new president, following in the footsteps of my predecessor, Professor Noda, M.D., Ph.D. I am so honored to succeed him, who is the founder of this organization.
The JGOG offers excellent opportunities for gynecologic oncologists to perform clinical research. Our main goal is to carry out clinical studies that meet high international standards. Therefore, it is essential to create well-designed protocols that will answer important research questions, authorize highly competent institutions capable of putting such protocols into practice, and establish an independent data center for case management. The JGOG has promoted the structure required to meet these conditions. Currently, the number of full members stands at 845 and the number of institutions authorized to participate in JGOG's clinical trials was 203 as of June 1, 2011. Our next challenge is to discover how to strengthen the audit system of institutions and improve the quality of clinical research. The JGOG is one of the organizations in Japan that allows high quality phase III studies to be implemented, and has expanded its activities by supporting development of new drugs and clinical trials, as well as engaging in international joint research. Also, the JGOG is a unique organization that actively promotes international studies in cooperation with overseas organizations.